Concepedia

Ildiko Lingvay

IL

Statistics

Publications

137

Citations

26.6K

H-Index

64

Active since

2007

Affiliations

The University of Texas Southwestern Medical Center(Current)

Novo Nordisk (Denmark)

Southwestern Medical Center

Harvard University

Ildiko Lingvay is an author at The University of Texas Southwestern Medical Center specializing in medicine, pharmacotherapy, and diabetes mellitus.

ORCID

Publications per year

2007–2025

137

Publications

137

Once-Weekly Semaglutide in Adults with Overweight or Obesity

John Wilding, Rachel L. Batterham, Salvatore Calanna et al. · New England Journal of Medicine · 2021 · 4.5K citations · Full text

, , +11

Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes

A. Michael Lincoff, Kirstine Brown‐Frandsen, Helen M. Colhoun et al. · New England Journal of Medicine · 2023 · 2.6K citations · Full text

, , +17

Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes

Mansoor Husain, Andreas L. Birkenfeld, Morten Donsmark et al. · New England Journal of Medicine · 2019 · 1.9K citations · Full text

, , +16

Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial

Melanie J. Davies, Louise Færch, Ole Kleist Jeppesen et al. · The Lancet · 2021 · 1.3K citations · Full text

, , +10

Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity

Domenica Rubino, Niclas Abrahamsson, Melanie J. Davies et al. · JAMA · 2021 · 1.2K citations · Full text

, , +17

1–5 of 137